{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:27:48Z","timestamp":1791088068274,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T00:00:00Z","timestamp":1276560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/sj.bjc.6605711","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T20:02:20Z","timestamp":1276632140000},"page":"265-274","source":"Crossref","is-referenced-by-count":32,"title":["DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma"],"prefix":"10.1038","volume":"103","author":[{"given":"S","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Bourantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stebbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tuthill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hatzimichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"issue":"Suppl 13","key":"BF6605711_CR1","first-page":"1508","volume":"22","author":"IT Aldoss","year":"2008","unstructured":"Aldoss IT, Weisenburger DD, Fu K, Chan WC, Vose JM, Bierman PJ, Bociek RG, Armitage JO (2008) Adult Burkitt lymphoma: advances in diagnosis and treatment. Oncology (Williston Park) 22 (Suppl 13): 1508\u20131517","journal-title":"Oncology (Williston Park)"},{"issue":"Suppl 10","key":"BF6605711_CR2","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104 (Suppl 10): 3009","journal-title":"Blood"},{"issue":"Suppl 3","key":"BF6605711_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1124\/pr.107.00106","volume":"60","author":"T Boutros","year":"2008","unstructured":"Boutros T, Chevet E, Metrakos P (2008) Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60 (Suppl 3): 261","journal-title":"Pharmacol Rev"},{"issue":"Suppl 993","key":"BF6605711_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/jcp.2007.047977","volume":"84","author":"G Brady","year":"2008","unstructured":"Brady G, Macarthur GJ, Farrell PJ (2008) Epstein-Barr virus and Burkitt lymphoma. Postgrad Med J 84 (Suppl 993): 372","journal-title":"Postgrad Med J"},{"issue":"Suppl 14","key":"BF6605711_CR5","first-page":"3352","volume":"59","author":"PG Corn","year":"1999","unstructured":"Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5\u2032 CpG island methylation. Cancer Res 59 (Suppl 14): 3352\u20133356","journal-title":"Cancer Res"},{"issue":"Suppl 2","key":"BF6605711_CR6","first-page":"R26","volume":"96","author":"M Esteller","year":"2007","unstructured":"Esteller M (2007) Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 96 (Suppl 2): R26\u2013R30","journal-title":"Br J Cancer"},{"issue":"Suppl 2","key":"BF6605711_CR7","first-page":"481","volume":"27","author":"U Grepmeier","year":"2005","unstructured":"Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M (2005) Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 27 (Suppl 2): 481\u2013488","journal-title":"Int J Oncol"},{"issue":"Suppl 49","key":"BF6605711_CR8","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1038\/sj.onc.1207089","volume":"22","author":"I Hoornaert","year":"2003","unstructured":"Hoornaert I, Marynen P, Goris J, Sciot R, Baens M (2003) MAPK phosphatase DUSP16\/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene 22 (Suppl 49): 7728","journal-title":"Oncogene"},{"issue":"Suppl 4","key":"BF6605711_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/gcc.20099","volume":"41","author":"A Hussain","year":"2004","unstructured":"Hussain A, Gutierrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K (2004) Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Genes Chromosomes Cancer 41 (Suppl 4): 321","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl 2","key":"BF6605711_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10555-008-9123-1","volume":"27","author":"SM Keyse","year":"2008","unstructured":"Keyse SM (2008) Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 27 (Suppl 2): 253","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl 5","key":"BF6605711_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ijc.20060","volume":"109","author":"AS Kibel","year":"2004","unstructured":"Kibel AS, Huagen J, Guo C, Isaacs WB, Yan Y, Pienta KJ, Goodfellow PJ (2004) Expression mapping at 12p12\u201313 in advanced prostate carcinoma. Int J Cancer 109 (Suppl 5): 668","journal-title":"Int J Cancer"},{"issue":"Suppl 10","key":"BF6605711_CR12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/leu.2008.192","volume":"22","author":"ED Lagadinou","year":"2008","unstructured":"Lagadinou ED, Ziros PG, Tsopra OA, Dimas K, Kokkinou D, Thanopoulou E, Karakantza M, Pantazis P, Spyridonidis A, Zoumbos NC (2008) c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia. Leukemia 22 (Suppl 10): 1899","journal-title":"Leukemia"},{"issue":"Suppl 5","key":"BF6605711_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","volume":"12","author":"MS Lindstrom","year":"2002","unstructured":"Lindstrom MS, Wiman KG (2002) Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 12 (Suppl 5): 381","journal-title":"Semin Cancer Biol"},{"issue":"Suppl 38","key":"BF6605711_CR14","doi-asserted-by":"publisher","first-page":"14988","DOI":"10.1073\/pnas.0707323104","volume":"104","author":"E Magnusdottir","year":"2007","unstructured":"Magnusdottir E, Kalachikov S, Mizukoshi K, Savitsky D, Ishida-Yamamoto A, Panteleyev AA, Calame K (2007) Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1. Proc Natl Acad Sci USA 104 (Suppl 38): 14988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 5","key":"BF6605711_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ijc.21270","volume":"117","author":"HE Rauhala","year":"2005","unstructured":"Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T (2005) Dual-specificity phosphatase 1 and serum\/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer 117 (Suppl 5): 738","journal-title":"Int J Cancer"},{"issue":"Suppl 5","key":"BF6605711_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2217\/14622416.7.5.747","volume":"7","author":"J Stebbing","year":"2006","unstructured":"Stebbing J, Bower M, Syed N, Smith P, Yu V, Crook T (2006) Epigenetics: an emerging technology in the diagnosis and treatment of cancer. Pharmacogenomics 7 (Suppl 5): 747","journal-title":"Pharmacogenomics"},{"issue":"Suppl 1","key":"BF6605711_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1182\/blood-2005-03-1194","volume":"107","author":"N Syed","year":"2006","unstructured":"Syed N, Smith P, Sullivan A, Spender LC, Dyer M, Karran L, O\u2019Nions J, Allday M, Hoffmann I, Crawford D, Griffin B, Farrell PJ, Crook T (2006) Transcriptional silencing of Polo-like kinase 2 (SNK\/PLK2) is a frequent event in B-cell malignancies. Blood 107 (Suppl 1): 250","journal-title":"Blood"},{"issue":"Suppl 28","key":"BF6605711_CR18","doi-asserted-by":"publisher","first-page":"26629","DOI":"10.1074\/jbc.M101981200","volume":"276","author":"T Tanoue","year":"2001","unstructured":"Tanoue T, Yamamoto T, Maeda R, Nishida E (2001) A novel MAPK phosphatase MKP-7 acts preferentially on JNK\/SAPK and p38 alpha and beta MAPKs. J Biol Chem 276 (Suppl 28): 26629","journal-title":"J Biol Chem"},{"issue":"Suppl 7","key":"BF6605711_CR19","first-page":"REVIEWS3009","volume":"3","author":"A Theodosiou","year":"2002","unstructured":"Theodosiou A, Ashworth A (2002) MAP kinase phosphatases. Genome Biol 3 (Suppl 7): REVIEWS3009","journal-title":"Genome Biol"},{"issue":"Suppl 46","key":"BF6605711_CR20","doi-asserted-by":"publisher","first-page":"34810","DOI":"10.1074\/jbc.M607484200","volume":"281","author":"SY Wang","year":"2006","unstructured":"Wang SY, Iordanov M, Zhang Q (2006) c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. J Biol Chem 281 (Suppl 46): 34810","journal-title":"J Biol Chem"},{"issue":"Suppl 23","key":"BF6605711_CR21","doi-asserted-by":"publisher","first-page":"9935","DOI":"10.1158\/0008-5472.CAN-08-2139","volume":"68","author":"JL Wiemels","year":"2008","unstructured":"Wiemels JL, Hofmann J, Kang M, Selzer R, Green R, Zhou M, Zhong S, Zhang L, Smith MT, Marsit C, Loh M, Buffler P, Yeh RF (2008) Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally. Cancer Res 68 (Suppl 23): 9935","journal-title":"Cancer Res"},{"issue":"Suppl 27","key":"BF6605711_CR22","doi-asserted-by":"publisher","first-page":"25651","DOI":"10.1074\/jbc.M501926200","volume":"280","author":"EA Willoughby","year":"2005","unstructured":"Willoughby EA, Collins MK (2005) Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem 280 (Suppl 27): 25651","journal-title":"J Biol Chem"},{"issue":"Suppl 4","key":"BF6605711_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10038-005-0235-y","volume":"50","author":"S Xu","year":"2005","unstructured":"Xu S, Furukawa T, Kanai N, Sunamura M, Horii A (2005) Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J Hum Genet 50 (Suppl 4): 159","journal-title":"J Hum Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605711","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:45:26Z","timestamp":1684413926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BF6605711"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605711","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}